Published January 1, 2017
| Version v1
Journal article
Open
Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer
- 1. Hacettepe Univ, Fac Med, Dept Med Biochem, Ankara, Turkey
- 2. Hacettepe Univ, Fac Med, Dept Urol, Ankara, Turkey
- 3. Hacettepe Univ, Fac Sci, Dept Chem, Ankara, Turkey
Description
Objective: Immunotherapy with intravesical Bacillus Calmette-Guerin (BCG) application is a gold standard treatment for high risk non-muscle invasive bladder cancer (NMIBC), despite its local and systemic side effects. We aimed to develop less toxic and more powerful therapeutic agents for the treatment of bladder cancer than live strain.
Files
10-4274-uob-905.pdf
Files
(684.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:9ee20076cf9bc2d697f350d2c286b2c0
|
684.3 kB | Preview Download |